Project Details


The goal of DECIDE is to reduce disease and death from alcohol-related and non-alcoholic fatty liver diseases by:
•Development and validation of novel biomarkers of hepatic inflammation.
•Easy, operational decision aids for case-finding in primary care.
•Biomarkers for prognostication and monitoring longitudinal changes in liver fibrosis.
•Validated, publicly scalable instruments using narrative medicine to reduce stigma towards liver disease, alcohol and obesity.
Effective start/end date01/11/202001/11/2025